Neuroinflammacil

For diagnostic patch testing in adults, the standard protocol involves the application of a minute quantity of Gold Trichloride (usually 0.1% to 0.5% concentration) in a petrolatum vehicle. This is applied using specialized delivery systems like Finn Chambers or T.R.U.E. Test systems.

• Standard Diagnostic Dose: Approximately 20 microliters of the petrolatum mix is applied to a 1-cm diameter chamber, which is then adhered to the patient's back.
• Duration of Exposure: The patch remains in contact with the skin for 48 hours.

Gold Trichloride is not routinely approved for use in children under the age of 12 unless a strong clinical suspicion of gold allergy exists (e.g., reactions to orthodontic appliances). If used, the concentration may be reduced to 0.05% or 0.1% to minimize the risk of primary sensitization or severe irritation. Pediatric testing should only be performed by a specialist in pediatric dermatology or allergy.

Renal Impairment

No dosage adjustment is required for topical diagnostic use. However, if systemic absorption is suspected in a patient with severe renal failure, caution is advised as gold is primarily cleared by the kidneys.

Hepatic Impairment

No adjustments are necessary for hepatic impairment, as Gold Trichloride does not undergo hepatic metabolism.

Elderly Patients

Elderly patients may have thinner skin (atrophy), which can lead to increased absorption or irritant reactions. Healthcare providers may choose a lower concentration or a shorter application time for patients over 75 years of age.

Gold Trichloride is never "taken" orally or self-administered. It is applied by a healthcare professional in a clinical setting.

1. 1Preparation: The skin on the upper back is cleaned and dried. It must be free of hair and active dermatitis.
2. 2Application: The Gold Trichloride patch is applied and secured with medical tape.
3. 3Activity Restrictions: During the 48-hour application period, the patient must keep the area dry. Showering, heavy sweating, and strenuous exercise are prohibited, as moisture can cause the patch to detach or the chemical to leach, leading to inaccurate results.
4. 4Removal: After 48 hours, the healthcare provider removes the patch.
5. 5Reading: The site is evaluated 30 minutes after removal and again at 72 to 96 hours. A final reading at 7 days is often recommended, as gold reactions are notoriously delayed.

In the context of diagnostic testing, a "missed dose" refers to a patch that has fallen off prematurely. If the patch is removed or falls off before the 48-hour mark, the test is considered invalid. The patient should contact their doctor immediately to determine if the test needs to be restarted on a different skin site.

Systemic overdose of Gold Trichloride is extremely rare due to the diagnostic nature of its application. However, local "overdose" or hyper-reactivity can occur.

• Signs of Local Overdose: Severe blistering, skin necrosis (tissue death), or a "persistent positive reaction" that lasts for months.
• Emergency Measures: If a severe reaction occurs, the patch must be removed immediately, and the area washed with mild soap and water. Topical corticosteroids may be prescribed to reduce inflammation.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or remove the diagnostic patch without medical guidance.

Because Gold Trichloride is an allergenic extract, the most common side effects are localized to the site of application. These are often the intended result of the test in sensitized individuals.

• Erythema (Redness): A red, itchy patch at the site of application. This typically peaks between 72 and 96 hours.
• Pruritus (Itching): Intense itching at the test site is common and indicates a positive immune response.
• Papules: Small, raised bumps that feel firm to the touch.
• Localized Edema: Swelling of the skin directly under the test chamber.

• Vesiculation: Small blisters may form if the patient is highly sensitive to gold. These blisters may weep or crust over.
• Hyperpigmentation: A temporary darkening of the skin at the test site after the reaction has healed. This is more common in individuals with darker skin tones.
• Persistent Positive Reaction: Gold is unique in that positive patch test reactions can last for several weeks or even months after the patch has been removed.

• Excited Skin Syndrome (Angry Back): A state of skin hyper-reactivity where a strong positive reaction to Gold Trichloride causes other, unrelated test sites to appear positive as well.
• Skin Necrosis: Very rarely, a high concentration of Gold Trichloride can cause localized tissue death in extremely sensitive individuals.
• Secondary Infection: Scratching the itchy test site can lead to bacterial infections (e.g., impetigo or cellulitis).

> Warning: Stop taking Gold Trichloride and call your doctor immediately if you experience any of these.

• Anaphylaxis: While exceptionally rare with patch testing, symptoms include difficulty breathing, swelling of the face or throat, rapid heartbeat, and a sudden drop in blood pressure.
• Systemic Flare: In patients with a high degree of pre-existing sensitivity, a patch test can cause a "flare-up" of dermatitis in other parts of the body (e.g., the face or hands).
• Chrysiasis: A rare condition where gold deposits in the skin or eyes, leading to a blue-gray discoloration. This is typically only seen with systemic gold therapy but is a theoretical risk with repeated high-dose exposure.
• Fever and Malaise: General feeling of being unwell, which may indicate a systemic immune response.

• Sensitization: There is a small risk that the test itself could cause a patient to become allergic to gold when they were not previously (iatrogenic sensitization).
• Scarring: If a severe vesiculating reaction occurs and becomes infected, permanent scarring or hypopigmentation (loss of skin color) may result.

No FDA black box warnings currently exist for Gold Trichloride when used as a diagnostic allergenic extract. However, historical black box warnings for systemic gold salts (like gold sodium thiomalate) included risks of blood dyscrasias (bone marrow suppression) and renal toxicity. These risks are considered negligible for the diagnostic concentrations used in Gold Trichloride patch testing.

Report any unusual symptoms, especially those occurring far from the test site, to your healthcare provider immediately.

Gold Trichloride must only be administered by healthcare professionals trained in the application and interpretation of epicutaneous tests. Patients should be aware that the goal of this substance is to provoke a controlled allergic reaction; therefore, discomfort at the application site is expected in sensitized individuals.

No FDA black box warnings for Gold Trichloride.

• Allergic Reactions / Anaphylaxis Risk: Although Gold Trichloride is used to diagnose allergies, it can rarely cause a systemic allergic reaction. Facilities where testing is performed must be equipped with epinephrine and other emergency supplies.
• Active Dermatitis: Testing should never be performed on skin with active, widespread dermatitis (eczema). This can lead to "false positive" results due to the skin's heightened state of irritability, known as "Angry Back Syndrome."
• Immunosuppression: Patients taking systemic corticosteroids (e.g., prednisone) or other immunosuppressants may have suppressed immune responses, leading to false-negative results. These medications should typically be tapered or stopped (under medical supervision) before testing.
• UV Exposure: Patients must avoid sun exposure or tanning beds on the test site for at least one week prior to and during the testing period, as UV light can suppress the localized immune response.

• Skin Site Monitoring: The primary monitoring requirement is the visual inspection of the patch test site at 48 hours and again at 72-96 hours.
• Delayed Reading: Because gold reactions can be significantly delayed, patients should be instructed to monitor the site for up to 10 days and report any new redness or itching that develops after the initial office visits.
• No Routine Labs: Blood counts or kidney function tests are not routinely required for diagnostic patch testing unless systemic toxicity is suspected.

Gold Trichloride does not typically affect the central nervous system. Patients are generally safe to drive and operate machinery immediately after the patch is applied, provided they do not feel lightheaded or unwell due to the stress of the procedure.

There are no known direct interactions between alcohol and Gold Trichloride. However, alcohol can cause vasodilation (opening of blood vessels), which might increase itching or redness at the test site. It is advisable to limit alcohol consumption during the 96-hour testing window.

Discontinuation involves the removal of the patch by a healthcare provider. There is no "withdrawal syndrome" associated with Gold Trichloride. If a patient experiences an intolerable reaction before the 48-hour mark, they should contact their doctor for instructions on early removal.

> Important: Discuss all your medical conditions, especially any history of severe metal allergies or skin conditions, with your healthcare provider before starting Gold Trichloride testing.

• Active Topical Steroids at the Test Site: Applying corticosteroid creams (e.g., hydrocortisone, clobetasol) directly to the area where Gold Trichloride will be applied is strictly contraindicated. These medications suppress the local immune response, making the test result uninterpretable and likely resulting in a false negative.

• Systemic Corticosteroids: Oral or injectable steroids like Prednisone or Methylprednisolone can dampen the Type IV hypersensitivity reaction throughout the body. Most clinicians recommend being off systemic steroids for at least 2 to 4 weeks before testing.
• Biologic Agents: Medications used for psoriasis or rheumatoid arthritis (e.g., Adalimumab, Etanercept) may interfere with T-cell activation, which is necessary for a Gold Trichloride reaction to occur.

• Antihistamines: While antihistamines (e.g., Cetirizine, Loratadine) do not typically block the T-cell mediated reaction of a patch test, they may reduce the itching associated with a positive result, potentially making it harder for the patient to identify a burgeoning reaction.
• NSAIDs: High doses of non-steroidal anti-inflammatory drugs (e.g., Ibuprofen, Naproxen) may theoretically reduce the inflammatory response at the test site, though this is clinically debated.

• High-Nickel Foods: In some patients, cross-reactivity between gold and nickel exists. Consuming very high amounts of nickel-rich foods (like chocolate, nuts, and oats) during testing might theoretically increase skin irritability, though this is not a standard restriction.
• Alcohol: As mentioned, alcohol-induced flushing can exacerbate the discomfort of a positive test reaction.

• St. John's Wort: This herb can increase photosensitivity. If the test site is exposed to light, this could complicate the interpretation of the skin reaction.
• Turmeric/Curcumin: Known for anti-inflammatory properties, high doses of these supplements might theoretically dampen the localized immune response required for a positive test.

• MRI Scans: Gold is a metal. While the amount in a patch test is minuscule, the patch itself (if it contains metal foil) must be removed before an MRI. The Gold Trichloride remaining in the skin does not typically interfere with imaging.
• Gold Serum Levels: Testing with Gold Trichloride will not significantly alter blood tests for gold levels unless an extremely large surface area is tested.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those for skin conditions or autoimmune diseases.

Gold Trichloride must NEVER be used in the following circumstances:

1. 1Known Anaphylactic Reaction to Gold: If a patient has a documented history of life-threatening systemic allergic reactions to gold, patch testing is too risky and is absolutely contraindicated.
2. 2Severe Active Dermatitis: Testing on skin that is currently inflamed, broken, or infected (Status Eczematicus) is contraindicated because it leads to uninterpretable results and significant patient distress.
3. 3Acute Systemic Illness: Patients with high fever or acute infections should postpone testing until they have recovered to ensure their immune system is in a baseline state.

Conditions requiring careful risk-benefit analysis include:

• Pregnancy: While topical diagnostic testing is not known to be teratogenic, most clinicians prefer to wait until after delivery to avoid any unnecessary immune stimulation.
• Recent Sunburn: Sunburned skin has altered immune cell function (Langerhans cell depletion), which can lead to false-negative results. Testing should be delayed by at least 2 weeks after a sunburn has healed.
• History of Keloids: Patients prone to keloid (thick, raised) scarring should be warned that a severe positive reaction could potentially trigger a keloid at the test site.

Patients who react to Gold Trichloride may also show cross-sensitivity to other noble metals. The most common associations include:

• Palladium: Often used in dental alloys and jewelry.
• Nickel: The most common metal allergen; many gold-plated items contain a nickel under-layer.
• Copper: Frequently alloyed with gold to create "Rose Gold."

> Important: Your healthcare provider will evaluate your complete medical history and current skin health before prescribing Gold Trichloride for diagnostic use.

FDA Pregnancy Category C. There are no adequate and well-controlled studies of Gold Trichloride in pregnant women. Animal reproduction studies have not been conducted with diagnostic gold extracts. It is unknown whether Gold Trichloride can cause fetal harm when applied to the skin of a pregnant woman or can affect reproduction capacity. Because gold ions can theoretically cross the placenta, and because a diagnostic test is rarely an emergency, it is standard clinical practice to defer Gold Trichloride patch testing until after pregnancy.

It is not known whether gold ions from a topical patch test are excreted in human milk. However, given the minute doses used in diagnostic testing, the risk to a nursing infant is considered extremely low. Nevertheless, the patch should never be applied to the breast or chest area where an infant might come into direct contact with the chemical or the treated skin.

Gold Trichloride is not FDA-approved for routine use in the pediatric population. Children have more permeable skin and a developing immune system, which may increase the risk of sensitization. If gold allergy is suspected in a child (e.g., due to orthodontic work), testing should be performed by a specialist using lower concentrations (0.01% to 0.1%).

Clinical studies of Gold Trichloride did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, elderly patients may have a slower or less vigorous immune response, which can lead to "weaker" positive results that are harder to interpret. Additionally, the risk of skin irritation from the adhesive tape used to secure the patches is higher in the elderly.

In patients with chronic kidney disease (CKD), the clearance of any systemically absorbed gold would be reduced. While the amount absorbed from a patch test is negligible, clinicians should be cautious in patients with end-stage renal disease (ESRD), as they may have altered skin reactivity (uremic pruritus) that complicates the test interpretation.

No specific adjustments or precautions are required for patients with liver disease, as gold is not metabolized by the liver. However, patients with autoimmune liver diseases (like Primary Biliary Cholangitis) may have heightened immune sensitivity.

> Important: Special populations require individualized medical assessment and a cautious approach to diagnostic allergy testing.

Gold Trichloride ($AuCl_3$) acts as a potent hapten. The gold(III) ion is a strong electrophile that reacts with nucleophilic functional groups on skin proteins, particularly the sulfhydryl (-SH) groups of cysteine residues. This covalent binding creates a "neoantigen." This complex is recognized by the immune system as foreign. Specifically, it activates the signal transduction pathways in dendritic cells, leading to the upregulation of MHC class II molecules and co-stimulatory molecules (CD80, CD86). This process is essential for the activation of Th1 and Th17 cells, which mediate the delayed-type hypersensitivity reaction seen in allergic contact dermatitis.

• Dose-Response: There is a clear dose-response relationship; higher concentrations (0.5%) yield more robust reactions but also higher rates of irritant (non-allergic) reactions.
• Onset of Effect: The immunologic reaction is delayed. While some redness may appear at 24 hours, the definitive diagnostic reaction typically requires 48 to 96 hours to develop.
• Duration: The effect (the skin reaction) can be remarkably persistent, sometimes lasting 1-3 months, due to the slow clearance of gold-protein complexes from the dermis.

| Parameter | Value |

|---|---|

| Bioavailability | < 1% (Topical) |

| Protein Binding | > 95% (primarily Albumin) |

| Half-life | 10 - 30 days (Systemic) |

| Tmax | 48 - 72 hours (Local reaction) |

| Metabolism | None (Elemental) |

| Excretion | Renal 60-90%, Fecal 10-40% |

• Molecular Formula: $AuCl_3$ (often exists as a dimer, $Au_2Cl_6$)
• Molecular Weight: 303.33 g/mol
• Solubility: Highly soluble in water and ethanol; typically formulated in petrolatum for patch testing to ensure stability and skin contact.
• Structure: Gold Trichloride features a gold atom in the +3 oxidation state coordinated with three chlorine atoms. In its solid form, it forms dark red to orange crystals.

Gold Trichloride is classified as a Non-Standardized Allergenic Extract. It belongs to the therapeutic category of Diagnostic Aids (Skin Test). Within the EPC system, it is grouped with other metal haptens like Nickel Sulfate and Cobalt Chloride, despite its various regulatory associations with plant and food extracts.